These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8015645)

  • 1. Increase of calcitriol during treatment with protein-reduced diet in patients with renal failure.
    Wilske J; Attman PO
    Nephron; 1994; 66(4):421-5. PubMed ID: 8015645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term control of hyperparathyroidism in advanced renal failure by low-phosphorus low-protein diet supplemented with calcium (without changes in plasma calcitriol).
    Combe C; Morel D; de Précigout V; Blanchetier V; Bouchet JL; Potaux L; Fournier A; Aparicio M
    Nephron; 1995; 70(3):287-95. PubMed ID: 7477615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum phosphate, parathyroid hormone and vitamin D metabolites in patients with chronic renal failure: effect of aluminum hydroxide administration.
    Takamoto S; Onishi T; Morimoto S; Imanaka S; Tsuchiya H; Seino Y; Yokokawa T; Iida N; Kumahara Y
    Nephron; 1985; 40(3):286-91. PubMed ID: 3839293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early treatment of secondary hyperparathyroidism in moderate renal insufficiency: low-phosphorus diet versus calcium carbonate].
    Aresté N; Amor J; Cambil T; Salgueira M; Sánchez-Palencia R; Páez C; Gómez O; Palma A
    Nefrologia; 2003; 23 Suppl 2():64-8. PubMed ID: 12778857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between serum vitamin D metabolites and dietary intake of phosphate in patients with early renal failure.
    Tessitore N; Venturi A; Adami S; Roncari C; Rugiu C; Corgnati A; Bonucci E; Maschio G
    Miner Electrolyte Metab; 1987; 13(1):38-44. PubMed ID: 3587183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Levels of dihydroxyvitamin D3 and hydroxyvitamin D in patients with chronic renal insufficiency].
    Lazarević M; Poskurica M; Djukanović Lj; Babić Lj; Metiljević S
    Srp Arh Celok Lek; 1996; 124 Suppl 1():108-11. PubMed ID: 9102866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure.
    St John A; Thomas MB; Davies CP; Mullan B; Dick I; Hutchison B; van der Schaff A; Prince RL
    Nephron; 1992; 61(4):422-7. PubMed ID: 1501739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?
    Ghazali A; Fardellone P; Pruna A; Atik A; Achard JM; Oprisiu R; Brazier M; Remond A; Morinière P; Garabedian M; Eastwood J; Fournier A
    Kidney Int; 1999 Jun; 55(6):2169-77. PubMed ID: 10354266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function.
    Moosgaard B; Vestergaard P; Heickendorff L; Mosekilde L
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):35-42. PubMed ID: 17201799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of diet in the management of osteodystrophy during progressive renal insufficiency].
    Martínez I; Saracho R; Ocharán J; Muñoz RI; Montenegro J
    Nefrologia; 2003; 23 Suppl 2():57-63. PubMed ID: 12778856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An importance of vitamin D metabolites assessment in patients with impaired renal function].
    Sulková S; Fortová M; Uhrová J; Zima T
    Vnitr Lek; 2004 Jul; 50(7):510-8. PubMed ID: 15323258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D3 metabolites in chronic renal failure and after renal transplantation.
    Lucas PA; Woodhead JS; Brown RC
    Nephrol Dial Transplant; 1988; 3(1):70-6. PubMed ID: 3132643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure.
    Rix M; Andreassen H; Eskildsen P; Langdahl B; Olgaard K
    Kidney Int; 1999 Sep; 56(3):1084-93. PubMed ID: 10469378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-dihydroxycholecalciferol and parathyroid hormone in advanced chronic renal failure: effects of simultaneous protein and phosphorus restriction.
    Lucas PA; Brown RC; Woodhead JS; Coles GA
    Clin Nephrol; 1986 Jan; 25(1):7-10. PubMed ID: 3754187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin in chronic renal failure.
    Franck H; Keck E; Issa S; Krüskemper HL; von Lilienfeld-Toal H
    Exp Clin Endocrinol; 1988 May; 91(2):202-6. PubMed ID: 3409970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone turnover and 1,25-dihydroxycholecalciferol during treatment with phosphate binders.
    Turner C; Compston J; Mak RH; Vedi S; Mellish RW; Haycock GB; Chantler C
    Kidney Int; 1988 May; 33(5):989-95. PubMed ID: 3392888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose alfacalcidol controls secondary hyperparathyroidism in predialysis chronic kidney disease.
    Reichel H
    Nephron Clin Pract; 2010; 114(4):c268-76. PubMed ID: 20090369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do limited changes in phosphate intake modulate 1,25(OH)2D3 levels in early renal failure?
    Seidel A; Stein G; Schneider S; Schmidt-Gayk H; Ritz E
    Clin Nephrol; 1991 Dec; 36(6):274-80. PubMed ID: 1769138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.